[Form 4] FMC CORP Insider Trading Activity

Rhea-AI Filing Summary

Jacqueline Scanlan, Executive VP & Chief HRO of FMC Corporation (FMC), reported two dispositions of common stock on 09/29/2025. She sold 3,790 shares at $34.00 and 5,177 shares at $33.64, reducing her direct beneficial ownership to 27,867 shares after the transactions. The filing notes the 3,790-share sale executed automatically under a Rule 10b5-1 trading plan adopted May 16, 2025. The Form 4 was signed by an attorney-in-fact on 09/30/2025.

Positive

• Transparent disclosure of insider transactions with transaction dates, prices, and post-transaction holdings
• Use of a Rule 10b5-1 trading plan for at least one sale, indicating scheduled execution and adherence to insider trading protocols
• Form signed by attorney-in-fact, showing formal execution of the filing

Negative

• Reduction in direct ownership by 8,967 shares, lowering reported holdings to 27,867 shares

Insights

Financial Analyst

TL;DR Insider sales were routine and executed under a 10b5-1 plan; total reported disposal was 8,967 shares.

The Form 4 documents two non-derivative dispositions totaling 8,967 common shares on 09/29/2025, at prices of $34.00 and $33.64. The filing explicitly states the 3,790-share sale occurred automatically under a Rule 10b5-1 plan adopted 05/16/2025, indicating preplanned execution rather than opportunistic timing. Post-transaction direct ownership is reported as 27,867 shares. For investors, these are routine insider liquidity events; no derivative instruments or additional contingent transactions are reported in this filing.

Corporate Governance Expert

TL;DR Disclosure aligns with standard governance practices; use of 10b5-1 plan is noted and Form 4 is properly signed.

The Form 4 provides clear disclosure of the officer's share disposals and cites a 10b5-1 trading plan for at least one sale, which supports compliance with insider trading controls. The document is executed by an attorney-in-fact and includes dates and prices for each transaction. There are no indications in this filing of unusual timing, related-party transactions, or derivative-based compensation changes. The filing appears routine from a governance and compliance perspective.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Scanlan Jacqueline

(Last) (First) (Middle)

C/O FMC CORPORATION

2929 WALNUT STREET

(Street)

PHILADELPHIA PA 19104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FMC CORP [ FMC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive VP & Chief HRO

3. Date of Earliest Transaction (Month/Day/Year)
09/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/29/2025		S		3,790	D	$34	33,044	D(1)
Common Stock	09/29/2025		F		5,177	D	$33.64	27,867	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported sale of 3,790 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

	/s/ Sara V. Ponessa, as attorney-in-fact for Jacqueline Scanlan	09/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did FMC insider Jacqueline Scanlan report on Form 4 (FMC)?

The filing reports two dispositions on 09/29/2025: 3,790 shares sold at $34.00 and 5,177 shares sold at $33.64.

How many shares does Jacqueline Scanlan beneficially own after the reported trades?

After the reported transactions, Jacqueline Scanlan's direct beneficial ownership is reported as 27,867 shares.

Was any sale executed under a 10b5-1 trading plan?

Yes. The filing states the 3,790-share sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted May 16, 2025.

When was the Form 4 signed and by whom?

The Form 4 is signed /s/ Sara V. Ponessa, as attorney-in-fact for Jacqueline Scanlan on 09/30/2025.

Do the transactions include derivative instruments or option exercises?

No. The filing lists only non-derivative common stock dispositions and no derivative securities or option exercises are reported.